INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 August 2013
Total net assets |
£172.0m |
NAV per share |
311.8p |
Share price |
269.0p |
Total value of unquoted investments |
£26.6m |
Total number of portfolio companies |
75 |
Cash |
2% NAV |
Cash committed and reserved to unquoted investments |
(3.5%) NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
7.4 |
Celgene |
7.3 |
Biogen |
7.3 |
Gilead |
7.2 |
Regeneron |
5.1 |
Alexion |
4.2 |
Incyte |
3.4 |
Aptiv |
3.4 |
Onyx |
3.4 |
Vertex |
3.0 |
|
----------- |
Total |
51.7 |
Geographical Allocation |
% |
United States & Canada |
91 |
Europe |
7 |
Cash |
2 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
83 |
Unquoted |
15 |
Cash |
2 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 SEPTEMBER 2013